| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | F5 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | RPL10A | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | ZDHHC4 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | CCDC17 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | TMEM65 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | UCN | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | SLC5A2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | ALOX15B | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | SUPV3L1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | RP11-350O14.18 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
